Latest News
The company will need to significantly boost revenue and earnings growth.
Via The Motley Fool · October 9, 2025
Investors need to stop ignoring this attractive stock.
Via The Motley Fool · October 9, 2025
Non-lethal weapons company Byrna (NASDAQ:BYRN) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 35.1% year on year to $28.18 million. Its GAAP profit of $0.09 per share was 40.6% above analysts’ consensus estimates.
Via StockStory · October 9, 2025
Only 2.5% of Americans have $1 million saved for retirement. Here's what that means and how to start building wealth now.
Via The Motley Fool · October 9, 2025
Why Did TMC Stock Surge 10% Premarket Today?stocktwits.com
Via Stocktwits · October 9, 2025
HSBC Lifts Plug Power Price Target Amid Clean Tech Optimismstocktwits.com
Via Stocktwits · October 9, 2025
USDJPY met the second target of 150.90-151.45 whilst managing to break above it two days ago.
Via Talk Markets · October 9, 2025
The Latin American financial services company is growing rapidly and doesn't appear to be slowing down anytime soon.
Via The Motley Fool · October 9, 2025
Via The Motley Fool · October 9, 2025
Buying Bitcoin via an ETF is a great move.
Via The Motley Fool · October 9, 2025
After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.
Via MarketBeat · October 9, 2025
Marvell just announced a multibillion-dollar buyback program and deepened ties with Nvidia. Will this be enough for the stock to skyrocket?
Via The Motley Fool · October 9, 2025
Have shares in this electric automaker finally bottomed out?
Via The Motley Fool · October 9, 2025
The deal follows Roche's plan to buy 89bio, another MASH-focused biotech company.
Via Investor's Business Daily · October 9, 2025
Delta reported Q3 EPS of $1.71 and revenue of $16.7 billion, topping expectations and signaling strong momentum for 2025.
Via Talk Markets · October 9, 2025
The software company has a lot of growth potential, but its financials haven't been all that impressive.
Via The Motley Fool · October 9, 2025
YETI Holdings excels with 23% EBIT growth, a 39.5% ROIC, and strong cash flow, making it a prime Caviar Cruise quality investment candidate.
Via Chartmill · October 9, 2025
The Pound Sterling weakens further against the US Dollar as the Greenback rebounds after a mild corrective move.
Via Talk Markets · October 9, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via Chartmill · October 9, 2025
Here are safe ways to earn over 4% on your retirement savings without taking big risks.
Via The Motley Fool · October 9, 2025
Via Benzinga · October 9, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · October 9, 2025
The worst-performing stock on this list is up 2,300% versus Nvidia's nearly 1,000% gain since its ChatGPT boost.
Via The Motley Fool · October 9, 2025
Roche has a promising GLP-1 drug that is entering phase 3 trials.
Via The Motley Fool · October 9, 2025